Tigecycline-Induced Tooth Discoloration in Children Younger than Eight Years-Reference-Cited by-同舟云学术

Tigecycline-Induced Tooth Discoloration in Children Younger than Eight Years

Published:2021-08-17 Issue:9 Volume:65 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Zhu Zhengyi¹^ORCID,Yu Qi²,Qi Ganggang²,Yang Jufei¹,Ni Yinghua¹,Ruan Wenhua³,Fang Luo⁴^ORCID

Affiliation:

1. Department of Pharmacy, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang, China

2. Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Clinical Research Center for Oral Disease of Zhejiang Province, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, Zhejiang, China

3. Department of Stomatology, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang, China

4. Department of Pharmacy, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China

Abstract

Tetracycline may cause tooth discoloration when used in young children during tooth development. Whether tigecycline, a tetracycline derivative, has either a similar adverse event or not remains unclear.

Funder

Zhejiang Province Human Resources and Social Security Department

National Natural Science Foundation of China

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00854-21

Reference25 articles.

1. Tigecycline: A Critical Analysis

2. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)

3. Kimberlin DWBM, Jackson MA, Long SS (ed). 2018. American Academy of Pediatrics. Tetracyclines. Red Book: 2018 report of the Committee on Infectious Diseases, 31st ed. American Academy of Pediatrics, Itasca, IL.

4. Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies

5. Preliminary experience with tigecycline treatment for severe infection in children

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety profiles of tetracycline-class drugs: a pharmacovigilance analysis of the FAERS database;Expert Opinion on Drug Safety;2024-09-04

2. Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database;Frontiers in Pharmacology;2024-07-26

3. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient;International Journal of Antimicrobial Agents;2024-06

4. Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report;Expert Opinion on Drug Safety;2024-05-28

5. Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis;Materials Today Bio;2023-10